BioGaia AB (publ) (LON:0GTN)
105.63
+0.23 (0.21%)
At close: Oct 21, 2025
BioGaia AB Market Cap
BioGaia AB has a market cap or net worth of 849.51 million as of October 23, 2025. Its market cap has increased by 4.22% in one year.
Market Cap
849.51M
Enterprise Value
791.56M
Revenue
115.46M
Ranking
n/a
PE Ratio
34.06
Stock Price
105.63
Market Cap Chart
Since December 31, 1998, BioGaia AB's market cap has increased from 13.43M to 849.51M, an increase of 6,223.70%. That is a compound annual growth rate of 16.72%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 22, 2025 | 849.51M | 3.72% |
Dec 30, 2024 | 819.04M | 2.96% |
Dec 29, 2023 | 795.50M | 18.39% |
Dec 30, 2022 | 671.91M | -21.59% |
Dec 30, 2021 | 856.92M | -11.97% |
Dec 30, 2020 | 973.47M | 61.96% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AstraZeneca | 194.46B |
HSBC Holdings | 169.14B |
Shell | 157.36B |
Unilever | 115.42B |
Rolls-Royce Holdings | 95.48B |
Rio Tinto Group | 88.76B |
British American Tobacco p.l.c. | 82.97B |
GSK plc | 66.17B |